Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 1
2019 1
2021 1
2022 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA, Goere D, Baratti D, Nizri E, Morris DL, Glehen O, Sardi A, Barrios P, Quénet F, Villeneuve L, Gómez-Portilla A, de Hingh I, Ceelen W, Pelz JOW, Piso P, González-Moreno S, Van Der Speeten K, Deraco M; Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE). Kusamura S, et al. JAMA Surg. 2021 Mar 1;156(3):e206363. doi: 10.1001/jamasurg.2020.6363. Epub 2021 Mar 10. JAMA Surg. 2021. PMID: 33502455 Free PMC article.
Hyperthermic intraperitoneal chemotherapy in colorectal cancer.
Fisher OM, Brown C, Esquivel J, Larsen SG, Liauw W, Alzahrani NA, Morris DL, Kepenekian V, Sourrouille I, Dumont F, Tuech JJ, Ceribelli C, Doussot B, Sgarbura O, Alhosni M, Quenet F, Glehen O, Cashin PH; Peritoneal Surface Oncology Group International (PSOGI), Nordic Peritoneal Oncology Group (NPOG), American Society for Peritoneal Surface Malignancy (ASPSM) and BIG-RENAPE Groups. Fisher OM, et al. BJS Open. 2024 May 8;8(3):zrae017. doi: 10.1093/bjsopen/zrae017. BJS Open. 2024. PMID: 38722737 Free PMC article.
Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM.
Vandecaveye V, Rousset P, Nougaret S, Stepanyan A, Otero-Garcia M, Nikolić O, Hameed M, Goffin K, de Hingh IHJ, Lahaye MJ; European Society of Gastrointestinal and Abdominal Radiology (ESGAR); European Society of Urogenital Radiology (ESUR); Peritoneal Surface Oncology Group International (PSOGI); European Association of Nuclear Medicine (EANM). Vandecaveye V, et al. Eur Radiol. 2024 Nov 5. doi: 10.1007/s00330-024-11124-5. Online ahead of print. Eur Radiol. 2024. PMID: 39499302
Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study.
Cashin PH, Esquivel J, Larsen SG, Liauw W, Alzahrani NA, Morris DL, Kepenekian V, Sourrouille I, Dumont F, Tuech JJ, Ceribelli C, Doussot B, Sgarbura O, Quenet F, Glehen O, Fisher OM; Peritoneal Surface Oncology Group International (PSOGI); Nordic Peritoneal Oncology Group (NPOG); American Society for Peritoneal Surface Malignancy (ASPSM); BIG-RENAPE Groups. Cashin PH, et al. EClinicalMedicine. 2022 Nov 24;55:101746. doi: 10.1016/j.eclinm.2022.101746. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36457647 Free PMC article.
Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups. Alzahrani NA, et al. J Surg Oncol. 2019 Mar;119(3):336-346. doi: 10.1002/jso.25277. Epub 2018 Dec 16. J Surg Oncol. 2019. PMID: 30554404